Articles dans des revues avec comité de lecture (237)

  1. 33. Descamps, O. S., Rietzschel, E. R., Laporte, A., Buysschaert, I., De Raedt, H., Elegeert, I., Chenot, F., Lengele, J. P., Carlier, S., Vanderheeren, P., Liénart, F., Friart, A., Guillaume, M., Vandekerckhove, H., Maudens, G., Mertens, A. A., Van De Borne, P., Bondue, A., & De Sutter, J. (2020). Feasibility and cost of FH cascade screening in Belgium (BEL-CASCADE) including a novel rapid rule-out strategy. Acta cardiologica. doi:10.1080/00015385.2020.1820683
  2. 34. De Becker, B., Coremans, C., Chaumont, M., Delporte, C., Van Antwerpen, P., Franck, T., Rousseau, A., Zouaoui Boudjeltia, K., Cullus, P., & Van De Borne, P. (2019). Severe Hypouricemia Impairs Endothelium-Dependent Vasodilatation and Reduces Blood Pressure in Healthy Young Men: A Randomized, Placebo-Controlled, and Crossover Study. Journal of the American Heart Association, 8(23), e013130. doi:10.1161/JAHA.119.013130
  3. 35. Morra, S., Hossein, A., Gorlier, D., Rabineau, J., Chaumont, M., Migeotte, P.-F., & Van De Borne, P. (2019). Modification of the mechanical cardiac performance during end-expiratory voluntary apnea recorded with ballistocardiography and seismocardiography. Physiological measurement, 40(10), 105005. doi:10.1088/1361-6579/ab4a6a
  4. 36. Chaumont, M., Van De Borne, P., Bernard, A.-M., Van Muylem, A., Deprez, G., Ullmo, J., Starczewska, E., Briki, R., de Hemptinne, Q., Zaher, W., & Debbas, N. (2019). Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. American journal of physiology. Lung cellular and molecular physiology, 316(5), L705-L719. doi:10.1152/ajplung.00492.2018
  5. 37. De Becker, B., Borghi, C., Burnier, M., & Van De Borne, P. (2018). Uric acid and hypertension: a focused review and practical recommendations. Journal of hypertension. doi:10.1097/HJH.0000000000001980
  6. 38. Landreani, F., Caiani, E. G., Golier, D., Hossein, A., Rabineau, J., Migeotte, P.-F., & Van De Borne, P. (2018). Heartbeat Detection Using Three-Axial Seismocardiogram Acquired by Mobile Phone. Computing in Cardiology, 2018-September, 8743812. doi:10.22489/CinC.2018.215
  7. 39. Lemogoum, D., Halle, M. P. E., Mboule, R. D., Van De Borne, P., Lele, C. E. B., Kamdem, F., Doualla, M. S., Luma, H., Hermans, M. P., & Van Bortel, L. (2018). Arterial stiffness in black African ancestry patients with chronic kidney disease living in Cameroon. Cardiovascular Diagnosis and Therapy, 8(4), 450-459. doi:10.21037/cdt.2018.04.04
  8. 40. Janssen, C., Grassi, G., Laude, D., & Van De Borne, P. (2018). Sympathetic baroreceptor regulation during hypoxic hypotension in humans: New insights. Journal of hypertension, 36(5), 1188-1194. doi:10.1097/HJH.0000000000001653
  9. 41. Oumeiri, B. E., McEntee, K., Annoni, F., Herpain, A., Vanden Eynden, F., Jespers, P., Van Nooten, G., & Van De Borne, P. (2018). Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats. BMC cardiovascular disorders, 18(1), 99. doi:10.1186/s12872-018-0831-3
  10. 42. Ngatchou Djomo, W., Lemogoum, D., Melot, C., Guimfacq, V., Van De Borne, P., Wautrecht, J.-C., Hermans, M. P., Van Bortel, L., & Leeman, M. (2018). Arterial stiffness and cardiometabolic phenotype of Cameroonian Pygmies and Bantus. Journal of hypertension, 36(3), 520-527. doi:10.1097/HJH.0000000000001577
  11. 43. Lemogoum, D., Ngatchou Djomo, W., Bika Lele, C., Okalla, C., Leeman, M., Degaute, J.-P., & Van De Borne, P. (2018). Association of urinary sodium excretion with blood pressure and risk factors associated with hypertension among Cameroonian pygmies and bantus: A cross-sectional study. BMC cardiovascular disorders, 18(1), 49. doi:10.1186/s12872-018-0787-3
  12. 44. Fitchett, D., Johansen, O. E., Inzucchi, S. S., Butler, J., Van De Borne, P., Zinman, B., Lachin, J. J., Wanner, C., Woerle, H. J., Hantel, S., & George, J. J. (2018). Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOMEVR trial. European heart journal, 39(5), 363-370. doi:10.1093/eurheartj/ehx511

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>